KLF13-Mediated CES2 Upregulation via p300-Dependent Acetylation Sensitizes Gastric Cancer Cells to Irinotecan

Name: KLF13-Mediated CES2 Upregulation via p300-Dependent Acetylation Sensitizes Gastric Cancer Cells to Irinotecan
Published: 2026-04-09T12:27:10+08:00